Cancer-driving H3G34V/R/D Mutations Block H3K36 Methylation and H3K36me3–MutSα Interaction

Jun Fang,Yaping Huang,Guogen Mao,Shuang Yang,Gadi Rennert,Liya Gu,Haitao Li,Guo-Min Li
DOI: https://doi.org/10.1073/pnas.1806355115
2018-01-01
Abstract:Significance Somatic mutations converting glycine 34 of histone H3 (H3G34) to a large side chain-containing residue (e.g., arginine, valine) cause pediatric gliomas; however, the mechanism of this is unknown. Because H3K36me3 is involved in mismatch repair (MMR) by recruiting MMR protein MutSα to chromatin, we hypothesized that H3G34R/V mutations block H3K36’s interactions with both MutSα and H3K36-specific methyltransferases, leading to MMR deficiency. We show here that this is indeed the case. Structural analysis revealed that H3G34 resides in a narrow substrate channel of the H3K36 trimethyltransferase SETD2. Thus, H3G34R/V mutations impair the catalytic activity of SETD2. H3G34R/V mutations also block the H3K36me3–MutSα interaction. Cells harboring H3G34R/V mutations display a mutator phenotype. This study reveals the molecular basis of how H3G34 mutations cause pediatric gliomas.
What problem does this paper attempt to address?